Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kalocsa – page 3

151 clinical trials in Kalocsa, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kalocsa at a glance
151
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

151 trials in Kalocsa

Open in trial search

A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Olema Oncology Inc.

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Syndax Pharmaceuticals Inc.

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Evaluating NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder Who Are Not Responding Adequately to Current Therapy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC

Myelofibrosis

Recruiting

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Study on the Effects of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:NBI-98782
  • Sponsor:Adeptio Pharmaceuticals Limited

Neoplasm

Recruiting

Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Patritumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Astrazeneca AB

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Grifols Therapeutics LLC

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Kalocsa

What the registry says about research in the country

01 Cardiovascular Research

Studies focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Key investigations include combination therapies with baxdrostat and research on blood pressure management.

  • Heart Failure Prevention
  • Resistant Hypertension
  • Atherosclerotic Disease

Novel approaches exploring cardiovascular outcomes in patients with various risk factors.

02 Metabolic Disorders

Comprehensive research into Type 2 Diabetes management and obesity treatments, evaluating new therapeutic approaches and combination medications.

  • Diabetes Management
  • Weight Management
  • Cardiovascular Safety Studies

Investigating innovative treatments to improve metabolic health outcomes.

03 Rheumatology Studies

Advanced research in rheumatoid arthritis and psoriatic arthritis treatments, including studies of novel biologics and long-term therapy effectiveness.

  • Arthritis Management
  • Osteoarthritis Treatment
  • Inflammatory Conditions

Evaluating new therapeutic options for chronic inflammatory conditions.

04 Mental Health Research

Innovative studies addressing major depressive disorder, schizophrenia, and other mental health conditions, focusing on new treatment approaches.

  • Depression Treatment
  • Schizophrenia Management
  • Alzheimer's Agitation

Testing novel therapeutic interventions for various psychiatric conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.